We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Saliva Test Detects Implant-Related Microbial Risks

By LabMedica International staff writers
Posted on 29 Jul 2025

Infection is the most frequent and preventable cause of dental implant failure, with microbial organisms contributing to inflammation, tissue degradation, and systemic immune response—often without visible early symptoms. More...

These implant-related complications can arise from pathogens such as Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, and others that evade early detection. Quick and accurate identification of these microbial threats remains a clinical challenge. Now, a new diagnostic test addresses this gap by offering a fast, noninvasive method to detect high-risk pathogens before implant failure occurs.

The SimplyTest Oral Health-IMPLANT test, developed by Spectrum Health Science (Huntsville, AL, USA), is a molecular assay designed to detect microbial species linked to peri-implant disease and implant failure. Sold under the SimplyTest brand, the test extends the company’s oral health diagnostic platform, which also includes screening tools for periodontal conditions. It is designed for both chairside and at-home saliva sample collection, using a proprietary preservation and analysis system. After the sample reaches the lab, results are delivered within 24 to 48 hours through a secure clinical portal. The report includes pathogen-specific data to support diagnostic conversations and personalized treatment planning. The solution identifies eight high-risk microbial species, including both bacteria and fungi, known to contribute to implant complications. This test aims to assist clinicians in preventive implant care, surgical planning, and cost-efficient treatment.

SimplyTest’s next-generation salivary diagnostics have been engineered to deliver fast screenings that detect microbial risks earlier, personalize care, and link oral health to systemic conditions. The broader SimplyTest Oral Health platform promotes a data-driven model of dentistry where early insight enables timely interventions and improved patient outcomes. The IMPLANT test enhances this effort by expanding diagnostic capabilities to a critical area of dental care. The company plans to continue leveraging this platform for further innovations that elevate clinical standards and reduce avoidable complications in oral healthcare.

“The SimplyTest Oral Health line is part of a broader effort to redefine the standard of care in dentistry and systemic healthcare by empowering providers with tools that reveal the root causes of oral and systemic conditions,” said Justin Hunt, CEO of Spectrum Health Science. “The IMPLANT test expands our platform’s reach to support preventative implant care, surgical planning, and cost-efficient treatment, which are key concerns for both clinicians and care organizations. It’s a strong example of how SimplyTest equips providers with timely insights that improve patient outcomes and help reduce avoidable expenses.”

Related Links:
Spectrum Health Science


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Specimen Radiography System
TrueView 200 Pro
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.